Kite Pharma, Inc. Business Combination, Contingent Consideration, Liability, Noncurrent
Kite Pharma, Inc. had Business Combination, Contingent Consideration, Liability, Noncurrent of $15.45 million as of 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent · last filed 2017-08-08
- 2017-06-30: Business Combination, Contingent Consideration, Liability, Noncurrent $15.45M.
- 2017-03-31: Business Combination, Contingent Consideration, Liability, Noncurrent $14.57M.
- 2016-12-31: Business Combination, Contingent Consideration, Liability, Noncurrent $14.22M.
- 2016-09-30: Business Combination, Contingent Consideration, Liability, Noncurrent $14.80M.
| Period end | Business Combination, Contingent Consideration, Liability, Noncurrent |
|---|---|
| 2017-06-30 | $15.45M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $14.57M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $14.22M 10-Q · filed 2017-08-08 |
| 2016-09-30 | $14.80M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $16.68M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $16.87M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $16.08M 10-K · filed 2017-02-28 |
| 2015-09-30 | $16.38M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $16.02M 10-Q · filed 2015-08-10 |